Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Cisplatin in Metastatic NSCLC
NCT01356303Phase 2Suspended
- Sponsor
- Ministry of National Guard Health Affairs
- Start
- Mar 2009
- Primary completion
- Aug 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132) in non-small cell lung cancer (NSCLC), sponsored by Ministry of National Guard Health Affairs. Started Mar 2009; status: suspended.
02
Drugs
docetaxelCisplatin micelle injection (HA132)
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01356303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01356303.